As an organization focused on women’s health, AWHP is thrilled by the launch of the White House Initiative of Women’s Health Research, an effort led by First Lady Dr. Jill Biden and directed by Dr. Carolyn Mazure. The initiative aims to spur extensive investment in women’s health research and close health disparities for women nationwide.

In collaboration with a diverse coalition of leading organizations dedicated to women’s health, we passionately advocate for accessible, affordable, and equitable preventive care. In the early days of 2024, we want to extend deep gratitude to the multitude of partners who join us on this transformative journey.

The Alliance for Women’s Health & Prevention (AWHP) was established with a clear mission: to ensure that all women and girls have access to affordable, high-quality preventive healthcare services. To reflect on our first year raising awareness and advocating for better preventive healthcare for all women and girls in the U.S., we recently issued our first End of Year (EOY) Report.

The U.S. faces a vaccine equity gap leading to disparities in vaccination rates, highlighted during the COVID-19 pandemic. To sustain progress, clear and universal CDC guidance, simplified recommendations, and caution against creating additional barriers are crucial for ensuring equitable access to vaccines and protecting the health of all communities.

A new survey commissioned by Pfizer and conducted by Survey Healthcare Global reveals confusion about the meningococcal vaccines and their associated recommendations. Luckily, an additional option may be on the horizon in the form of a pentavalent vaccine. The survey findings are now available on the AWHP website.

AWHP urges House lawmakers to reject cuts that may hinder biomedical research and harm vulnerable populations, advocating for a budget bill that restores agency funding to current levels, preserves the Agency for Healthcare Research and Quality, and prioritizes women’s and girls’ healthcare needs.